Clinical trial
The Effects of Hemoperfusion in Acute Type A Aortic Dissection Patients Undergoing Cardiopulmonary Bypass and Deep Hypothermic Circulatory Arrest: A Randomized, Controlled, Double-blinded Trial
NCT04007484 is registered in ClinicalTrials.gov with The Second Hospital of Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Hemoperfusion in Acute Type A Aortic Dissection Patients Undergoing Cardiopulmonary Bypass and Deep Hypothermic Circulatory Arrest: A Randomized, Controlled, Double-blinded Trial
- Lead sponsor
- The Second Hospital of Nanjing Medical University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 2, 2019
- Completion date
- December 30, 2020
- Enrollment
- 88 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute type a aortic dissection with arch involvement, cardiopulmonary bypass, deep hypothermic circulatory arrest